Sheller on Insider Exclusive “Deadly Drugs: Johnson & Johnson’s Risperdal”

0
Shares

Insider Exclusive Television Documentaries

2012-05-18

“Deadly Drugs: Johnson and Johnson’s Risperdal” examines the evolution of the drug Risperdal® from treatment of schizophrenia and extreme bipolar mania to off-label use in children and the elderly for behavior issues, sleep problems, and other uses, some which later became approved by the FDA. What is the cautionary tale? How are consumers and patients affected by the marketing of antipsychotic drugs?
View the documentary here.

Previous post

Sheller, P.C. Attorneys Honored Again in SuperLawyers 2012

Next post

Jamie Sheller presents at PBI "How to Properly Document Settlement Agreements"